| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 05/17/2006 | CN1771958A Application of thiobiazole pyrimidine derivative in preparing antiviral medicine |
| 05/17/2006 | CN1771956A Itraconazole dripping pill and its prepn |
| 05/17/2006 | CN1771946A Soft capsule composition of compound cold-treating medicine |
| 05/17/2006 | CN1771937A Externally applied podophyllotoxin ointment and its prepn |
| 05/17/2006 | CN1771926A Application of diacyl thiourea derivative in preparing antiviral medicine |
| 05/17/2006 | CN1771915A Oral disintegrated Anfenmame tablet for treating children's cold and its prepn |
| 05/17/2006 | CN1771914A Freeze dried polyene lecithin powder for injection and its prepn |
| 05/17/2006 | CN1771911A Re-dispersible nanometer particle of insoluble medicine and its prepn |
| 05/17/2006 | CN1771910A Nanometer particle of insoluble medicine and its prepn |
| 05/17/2006 | CN1256343C Chickweed total flavones , their production method , use and preparation containing the same |
| 05/17/2006 | CN1256328C Position seven substituted amine methyl fluoro quinolone derivative having antibacterial activity and its preparation method |
| 05/17/2006 | CN1256143C Chinese medicinal composite preparation against virus |
| 05/17/2006 | CN1256137C Chinese medicine for treating pulmonary tuberculosis |
| 05/17/2006 | CN1256136C Medicine for dispelling heat of liver and toxin to treat hepatitis B |
| 05/17/2006 | CN1256131C Chinese traditional medicine preparation Qimaishen for treating viral myocarditis and its manufacturing method |
| 05/17/2006 | CN1256122C Medicine for treating hepatitis A and B |
| 05/17/2006 | CN1256119C Traditional Chinese medicine preparation for treating nonspecific colonitis and its preparing process |
| 05/17/2006 | CN1256118C Medicine for curing chicken disease |
| 05/17/2006 | CN1256116C Method for extracting effective active component of rodgersia aesculifolia |
| 05/17/2006 | CN1256105C Oral liquid medicine from ferments of armilarilla tabescens |
| 05/17/2006 | CN1256099C Application of ivory powder for curing bone tuberculosis and osteomyelitis |
| 05/17/2006 | CN1256092C Methyleritrocina injection |
| 05/17/2006 | CN1256087C Application of aloelactone in preparation of medicine |
| 05/17/2006 | CN1256080C In-situ gel formation of pectins |
| 05/16/2006 | US7045660 [di(ether or thioether)heteroaryl or fluoro substituted aryl] compound or an N-oxide thereof or a salt thereof, useful for inhibiting the production or physiological effects of TNF in treatment of a patient suffering from a disease state associated with a detrimental excess of tumor necrosis factor |
| 05/16/2006 | US7045620 Crystal structure antibiotic; heating, dissolving, crystallization |
| 05/16/2006 | US7045536 Compound having anti-viral activity |
| 05/16/2006 | US7045525 Use of (R)-peniciclovir triphosphate for the manufacture of a medicament for the treatment of viral diseases |
| 05/16/2006 | US7045524 Bactericides; infection therapy; topical administering |
| 05/16/2006 | US7045522 8-Azabicyclo[3.2.1]oct-2-ene and -octane derivatives technical field |
| 05/16/2006 | US7045521 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents |
| 05/16/2006 | US7045509 Proteins and nucleic acids encoding same |
| 05/16/2006 | US7045507 Substituted tetracycline compounds as synergistic antifungal agents |
| 05/16/2006 | US7045505 Isolation nucleic acids; genetic engineering; diagnosis, therapy, prevention hematopoietic, nervous system disorders |
| 05/16/2006 | US7045500 Comprises peptide with heparin and/or lipopolysaccharide binding activity for use as treatment of endotoxic shock and endometriosis, anticoagulant, angiogenesis inhibitor, antiproliferative agent and contraceptive |
| 05/16/2006 | US7045335 Immunotherapy; genetic engineering; anticancer agents |
| 05/16/2006 | US7045323 Glutathione reductase for therapy and prophylaxis of aids |
| 05/16/2006 | US7045159 Antiviral substances from plant cuticular and epiciticular material |
| 05/16/2006 | US7045146 Treating the solid particle material with an amphiphilic substance and coating the material with a layer of a charged polyelectrolyte or with a multilayer comprising alternating layers of oppositely charged polyelectrolytes. |
| 05/16/2006 | US7045140 Therapeutic delivery of carbon monoxide |
| 05/16/2006 | US7045132 Comprises nucleotide sequences coding adhesion polypeptides for treating infection; bactericides; genetic vaccines |
| 05/16/2006 | US7045122 Salmonella vaccine |
| 05/16/2006 | US7045118 Delivery of compounds for the treatment of migraine through an inhalation route |
| 05/16/2006 | US7045115 Drugs for the diagnosis of tissue-reproductive activity or the treatment of proliferative diseases |
| 05/11/2006 | WO2006050303A2 Intravaginal treatment of vaginal infections with metronidazole compositions |
| 05/11/2006 | WO2006050250A2 Dose forms comprising vx-950 and their dosage regimen |
| 05/11/2006 | WO2006050219A2 Broadly cross-reactive hiv-1 neutralizing human monoclonal antibodies |
| 05/11/2006 | WO2006050035A1 Substituted 5-oxo pyrazoles and [1,2,4]triazoles as antiviral agents |
| 05/11/2006 | WO2006050034A1 Substituted 5-carboxyamide pyrazoles and [1,2,4]triazoles as antiviral agents |
| 05/11/2006 | WO2006049215A1 Combination drug for treating autoimmune disease |
| 05/11/2006 | WO2006049148A1 1β-METHYLCARBAPENEM DERIVATIVE |
| 05/11/2006 | WO2006048768A2 Kit of parts designed for implementing an antitumoral or antiviral treatment in a mammal |
| 05/11/2006 | WO2006048751A1 Polymorphic forms of 6-[2-(methylcarbamoyl)phenylsulfanyl]-3-e-[2-(pyridin-2-yl)ethenyl]indazole |
| 05/11/2006 | WO2006048457A1 Probiotica and polyphenol |
| 05/11/2006 | WO2006048446A1 Lactobacillus for preventing and/or treating chronique fatigue syndrome and associated diseases |
| 05/11/2006 | WO2006048430A1 SALTS OF N-ACYL-L-ASPARTATE-β-MONOESTER AND/OR OF N-ACYL-L-GLUTAMATE-Ϝ-MONOESTER, METHOD FOR THE PREPARATION THEREOF AND THEIR USE IN THERAPEUTIC OR COSMETIC COMPOSITIONS |
| 05/11/2006 | WO2006048336A2 Aryl pyrimidyl compounds, pharmaceutical compositions comprising them, their use as antimicrobial agents |
| 05/11/2006 | WO2006048156A1 Cyclic nonapeptide amides |
| 05/11/2006 | WO2006048139A1 Acylated nonadepsipeptides used as lysobactin derivatives |
| 05/11/2006 | WO2006047948A1 The use of human urinary kallidinogenase for the manufacture of a medicine for the treatment of sepsis |
| 05/11/2006 | WO2006047891A1 Polycyclic aromatics and derivatives thereof and processes for their preparation |
| 05/11/2006 | WO2006047872A1 Bacteriophage compositions |
| 05/11/2006 | WO2006047871A1 Encapsulated bacteriophage formulation |
| 05/11/2006 | WO2006047870A1 Stabilized bacteriophage formulations |
| 05/11/2006 | WO2006047868A1 Method of treating microorganisms in the oral cavity via photodynamic therapy employing a non-coherent light source |
| 05/11/2006 | WO2006034560A3 Prevention and treatment of mycoplasma-associated diseases |
| 05/11/2006 | WO2006034134A3 Antibacterial peptide with activity against b. anthracis |
| 05/11/2006 | WO2005018551A3 Oxime substituted imidazo-containing compounds |
| 05/11/2006 | WO2002055100A9 Method and composition for inhibition of tumor growth and enhancing an immune response |
| 05/11/2006 | US20060100436 Antimicrobial quinolones, their compositions, and uses |
| 05/11/2006 | US20060100415 aminalkylphosphonate-substituted vancomycin; chromatography; DIVINYLBENZENE-STYRENE COPOLYMER |
| 05/11/2006 | US20060100291 Antibacterial compounds |
| 05/11/2006 | US20060100258 Growth promotion method |
| 05/11/2006 | US20060100246 Synthesis of I kappa B kinase beta inhibitors that are 2-amino-4,6-disubstituted nicotinic acid ester analogs, by reacting an aryl ketone, an aldehyde and a cyanoacetate with an ammonium salt |
| 05/11/2006 | US20060100240 Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 05/11/2006 | US20060100233 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 05/11/2006 | US20060100227 Pyrimidine derivaties |
| 05/11/2006 | US20060100224 Piperidine ouracil used as a medicament for treating bacterial infections |
| 05/11/2006 | US20060100211 2-(3,4-dichlorophenylamino)-4-thiocyanato-5-nitro-pyrimidine; 2-chloro-4-(2-acetylamino-ethylamino)-5-trifluoromethyl-pyrimidine; lung cancer |
| 05/11/2006 | US20060100199 Novel condensed imidazole derivatives |
| 05/11/2006 | US20060100197 7,8,9,10-Tetrahydropyrido[2,3-b]azocine derivatives; CCR5 chemokine receptor antagonists; prophylactic for lymphadenopathy associated and/or human T-cell leukemia/lymphoma virus infections in peripheral mononuclear blood cells; AIDS; quaternization, oxidation, condensation, deprotecting, amidation |
| 05/11/2006 | US20060100150 Pharmacokinetic and pharmacodynamic modeling of erythropoietin administration |
| 05/11/2006 | US20060100139 Pharmaceutical used for treating HIV infection, the composition and uses thereof |
| 05/11/2006 | US20060099691 Production of complex carbohydrates |
| 05/11/2006 | US20060099276 Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate |
| 05/11/2006 | US20060099218 Method of strengthening foreign epitope presentation by mhc class i by inhibiting tap activity |
| 05/11/2006 | US20060099197 identifying a mammalian subject having an infection with said pathogenic Clostridium bacterium resistant to antibiotic, orally administering a therapeutically-effective concentration of Bacillus coagulans bacteria; reducing gastrointestinal colonization by a pathogenic Clostridium bacterium |
| 05/11/2006 | US20060099176 Administering system for interferon, includes a first step for detecting the number of interferon receptors on a surface of the cell, a second step for administering interferon being prepared so that an interferon dosage is determined according to number of IFN receptors on the cell surface |
| 05/11/2006 | US20060099174 Interferon-alpha induced genes |
| 05/11/2006 | US20060099166 Honey-based skin care preparation |
| 05/11/2006 | US20060099150 Compositions and methods for the transport of biologically active agents across cellular barriers |
| 05/11/2006 | DE102004053410A1 Cyclische Nonadepsipeptidamide Cyclic Nonadepsipeptidamide |
| 05/11/2006 | DE102004053407A1 Acylierte Nonadepsipeptide II Acylated nonadepsipeptides II |
| 05/11/2006 | CA2602070A1 Cyclic nonapeptide amides |
| 05/11/2006 | CA2589808A1 Combination drug for treating autoimmune disease |
| 05/11/2006 | CA2586704A1 Acylated nonadepsipeptides used as lysobactin derivatives |
| 05/11/2006 | CA2586619A1 Bacteriophage compositions |
| 05/11/2006 | CA2586611A1 Encapsulated bacteriophage formulation |
| 05/11/2006 | CA2586177A1 Polymorphic forms of 6-[2-(methylcarbamoyl)phenylsulfanyl]-3-e-[2-(pyridin-2-yl)ethenyl]indazole |
| 05/11/2006 | CA2586073A1 Aryl pyrimidyl compounds, pharmaceutical compositions comprising them, their use as antimicrobial agents |